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Introduction 
We develop a sheep thoracic spine interbody fusion model to study the suitability of 
polycaprolactone-based scaffold and recombinant human bone morphogenetic 
protein-2 (rhBMP-2) as a bone graft substitute within the thoracic spine. The surgical 
approach is a mini- open thoracotomy with relevance to minimally invasive deformity 
correction surgery for adolescent idiopathic scoliosis. To date there are no studies 
examining the use of this biodegradable implant in combination with biologics in a 
sheep thoracic spine model.  
 
Methods 
In the present study, six sheep underwent a 3-level (T6/7, T8/9 and T10/11) 
discectomy with randomly allocated implantation of a different graft substitute at each 
of the three levels; (i) calcium phosphate (CaP) coated polycaprolactone based 
scaffold plus 0.54µg rhBMP-2, (ii) CaP coated PCL- based scaffold alone or (iii) 
autograft (mulched rib head). Fusion was assessed at six months post-surgery.  
 
Results 
Computed Tomographic scanning demonstrated higher fusion grades in the rhBMP-2 
plus PCL- based scaffold group in comparison to either PCL-based scaffold alone or 
autograft. These results were supported by histological evaluations of the respective 
groups. Biomechanical testing revealed significantly higher stiffness for the rhBMP-2 
plus PCL- based scaffold group in all loading directions in comparison to the other 
two groups.  
 
Conclusions 
The results of this study demonstrate that rhBMP-2 plus PCL-based scaffold is a 
viable bone graft substitute, providing an optimal environment for thoracic interbody 
spinal fusion in a large animal model.   
